ACHIEVE LIFE SCIENCES INC (ACHV) Fundamental Analysis & Valuation

NASDAQ:ACHV • US0044685008

Current stock price

4 USD
-0.09 (-2.2%)
At close:
4 USD
0 (0%)
After Hours:

This ACHV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ACHV Profitability Analysis

1.1 Basic Checks

  • In the past year ACHV has reported negative net income.
  • ACHV had a negative operating cash flow in the past year.
  • In the past 5 years ACHV always reported negative net income.
  • In the past 5 years ACHV always reported negative operating cash flow.
ACHV Yearly Net Income VS EBIT VS OCF VS FCFACHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • With a Return On Assets value of -100.59%, ACHV is not doing good in the industry: 75.82% of the companies in the same industry are doing better.
  • ACHV has a Return On Equity of -155.72%. This is in the lower half of the industry: ACHV underperforms 64.80% of its industry peers.
Industry RankSector Rank
ROA -100.59%
ROE -155.72%
ROIC N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACHV Yearly ROA, ROE, ROICACHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACHV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHV Yearly Profit, Operating, Gross MarginsACHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ACHV Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ACHV has been increased compared to 1 year ago.
  • The number of shares outstanding for ACHV has been increased compared to 5 years ago.
  • ACHV has a better debt/assets ratio than last year.
ACHV Yearly Shares OutstandingACHV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACHV Yearly Total Debt VS Total AssetsACHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • ACHV has an Altman-Z score of -1.91. This is a bad value and indicates that ACHV is not financially healthy and even has some risk of bankruptcy.
  • ACHV's Altman-Z score of -1.91 is in line compared to the rest of the industry. ACHV outperforms 50.29% of its industry peers.
  • A Debt/Equity ratio of 0.26 indicates that ACHV is not too dependend on debt financing.
  • ACHV has a worse Debt to Equity ratio (0.26) than 66.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -1.91
ROIC/WACCN/A
WACCN/A
ACHV Yearly LT Debt VS Equity VS FCFACHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • ACHV has a Current Ratio of 5.14. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 5.14, ACHV perfoms like the industry average, outperforming 57.06% of the companies in the same industry.
  • A Quick Ratio of 5.14 indicates that ACHV has no problem at all paying its short term obligations.
  • ACHV has a Quick ratio (5.14) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 5.14
ACHV Yearly Current Assets VS Current LiabilitesACHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ACHV Growth Analysis

3.1 Past

  • The earnings per share for ACHV have decreased strongly by -22.12% in the last year.
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ACHV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.52% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.94%
EPS Next 2Y3.32%
EPS Next 3Y23.61%
EPS Next 5Y28.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACHV Yearly Revenue VS EstimatesACHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2021 2022 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
ACHV Yearly EPS VS EstimatesACHV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K -2K

More info and screens

Find the best growth stocksShow best growing peers

1

4. ACHV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACHV. In the last year negative earnings were reported.
  • Also next year ACHV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACHV Price Earnings VS Forward Price EarningsACHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACHV Per share dataACHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ACHV's earnings are expected to grow with 23.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y23.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACHV Dividend Analysis

5.1 Amount

  • ACHV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACHV Fundamentals: All Metrics, Ratios and Statistics

ACHIEVE LIFE SCIENCES INC

NASDAQ:ACHV (3/20/2026, 4:10:11 PM)

After market: 4 0 (0%)

4

-0.09 (-2.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-24
Inst Owners46.11%
Inst Owner Change47.77%
Ins Owners4.61%
Ins Owner Change7.57%
Market Cap212.92M
Revenue(TTM)N/A
Net Income(TTM)-52.35M
Analysts81.54
Price Target15.68 (292%)
Short Float %13.35%
Short Ratio11.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.21%
Min EPS beat(2)-6.75%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-4.14%
Min EPS beat(4)-10.29%
Max EPS beat(4)0.34%
EPS beat(8)3
Avg EPS beat(8)-5.36%
EPS beat(12)6
Avg EPS beat(12)-0.04%
EPS beat(16)7
Avg EPS beat(16)-3.08%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.5%
PT rev (3m)-3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.39%
EPS NY rev (1m)0%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.33
P/tB 6.7
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0
BVpS0.63
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.59%
ROE -155.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.14
Quick Ratio 5.14
Altman-Z -1.91
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-3.94%
EPS Next 2Y3.32%
EPS Next 3Y23.61%
EPS Next 5Y28.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.12%
OCF growth 3YN/A
OCF growth 5YN/A

ACHIEVE LIFE SCIENCES INC / ACHV Fundamental Analysis FAQ

What is the fundamental rating for ACHV stock?

ChartMill assigns a fundamental rating of 1 / 10 to ACHV.


What is the valuation status of ACHIEVE LIFE SCIENCES INC (ACHV) stock?

ChartMill assigns a valuation rating of 1 / 10 to ACHIEVE LIFE SCIENCES INC (ACHV). This can be considered as Overvalued.


What is the profitability of ACHV stock?

ACHIEVE LIFE SCIENCES INC (ACHV) has a profitability rating of 0 / 10.